alvocidib

cyclin dependent kinase 2 ; Homo sapiens







31 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31045274 Inhibition of cyclin E1 overcomes temozolomide resistance in glioblastoma by Mcl-1 degradation. 2019 Aug 1
2 30250647 Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response. 2018 Aug 31 1
3 28911822 Structural insights of cyclin dependent kinases: Implications in design of selective inhibitors. 2017 Dec 15 3
4 27259234 A novel arylbenzofuran induces cervical cancer cell apoptosis and G1/S arrest through ERK-mediated Cdk2/cyclin-A signaling pathway. 2016 Jul 5 1
5 27771926 Potential Use of Flavopiridol in Treatment of Chronic Diseases. 2016 1
6 23300027 Predicting the impact of single-nucleotide polymorphisms in CDK2-flavopiridol complex by molecular dynamics analysis. 2013 Jul 4
7 21575631 Sustained activation of ERK and Cdk2/cyclin-A signaling pathway by pemetrexed leading to S-phase arrest and apoptosis in human non-small cell lung cancer A549 cells. 2011 Aug 1 1
8 19535344 The effect of the cyclin-dependent kinase inhibitor flavopiridol on anaplastic large cell lymphoma cells and relationship with NPM-ALK kinase expression and activity. 2009 Jul 1
9 17123821 Design, synthesis, and antiproliferative and CDK2-cyclin a inhibitory activity of novel flavopiridol analogues. 2007 Jan 15 2
10 15689157 Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin. 2005 Feb 10 1
11 15818598 Transactivation of cyclin E gene by EWS-Fli1 and antitumor effects of cyclin dependent kinase inhibitor on Ewing's family tumor cells. 2005 Sep 1 1
12 16140252 Ligand binding affinity determined by temperature-dependent circular dichroism: cyclin-dependent kinase 2 inhibitors. 2005 Oct 15 1
13 15122251 Bioluminescent imaging of Cdk2 inhibition in vivo. 2004 Jun 1
14 15185335 Charge optimization of the interface between protein kinases and their ligands. 2004 Aug 2
15 15252147 Transcriptional signature of flavopiridol-induced tumor cell death. 2004 Jul 1
16 12457721 Flavopiridol, a cyclin dependent kinase (CDK) inhibitor, induces apoptosis by regulating Bcl-x in oral cancer cells. 2003 Jan 3
17 12533675 Flavopiridol-induced apoptosis is mediated through up-regulation of E2F1 and repression of Mcl-1. 2003 Jan 1
18 12598612 Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition. 2003 Feb 15 1
19 12852762 A computational model of binding thermodynamics: the design of cyclin-dependent kinase 2 inhibitors. 2003 Jul 17 3
20 11792416 Growth inhibition and apoptosis of myeloma cells by the CDK inhibitor flavopiridol. 2002 Mar 1
21 12054639 Structural basis for inhibition of cyclin-dependent kinase 9 by flavopiridol. 2002 Apr 26 2
22 11562278 Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents. 2001 Oct 1
23 10741717 Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells. 2000 Mar 1
24 10454206 Cyclin-dependent kinases: initial approaches to exploit a novel therapeutic target. 1999 May-Jun 1
25 10493518 Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol. 1999 Sep 15 2
26 16127615 Small molecule anticancer drugs. 1999 Jun 1
27 9639406 Cell cycle-independent induction of apoptosis by the anti-tumor drug Flavopiridol in endothelial cells. 1998 Jul 3 1
28 9802881 Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis. 1998 Nov 1 1
29 18465538 Flavopiridol Hoechst AG. 1998 Jun 1
30 8674031 Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. 1996 Jul 1 7
31 21541623 Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy. 1996 Dec 1